The outstanding properties of metal nanoclusters, stabilized with different scaffolds, i.e., proteins, nucleic acids, polymers and dendrimers, enable their application in a wide range of fields. The recent advances in the fabrication and synthesis of nanoclusters have revolutionized the design of biosensors, leading to significant improvements in the selective and sensitive determination of several targets. In particular, in recent years, copper nanoclusters (CuNCs) have attracted more attention mainly for their unique fluorescent properties, as well as their large Stokes shifts, low toxicity, and high biocompatibility. The high-photoluminescent features of CuNCs facilitate highly sensitive target detection even in complex biological matrices. For these reasons, in this work, we exploited the specific template-targeted CuNCs’ growth for the sensitive and accurate determination of human serum albumin (HSA) in urine and human serum. HSA is the most abundant protein in plasma, acting as a carrier for many key biological molecules such as hormones, fatty acids and steroids, and it contributes to the maintenance of the oncotic blood pressure. The concentration of HSA in body fluids greatly influences the state of health of the patients. Taking into account these considerations, the quantitative detection of human serum albumin plays a key role in the early diagnosis of serious pathological conditions such as albuminuria and albuminemia. Here, we present a CuNCs-based assay in which copper nanoclusters were used as fluorescent signal indicators to detect serum albumin in a complex biological matrix.
Functionalized nanoporous gold as a new biosensor platform for ultra-low quantitative detection of human serum albumin
